Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma

被引:46
作者
Lee, DKC
Jackson, CM
Currie, GP
Cockburn, WJ
Lipworth, BJ [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Asthma & Allergy Res Grp, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Tayside Ctr Gen Practice, Dundee DD1 9SY, Scotland
关键词
asthma; budesonide; combination inhalers; fluticasone; formoterol; inflammation; methacholine challenge; pulmonary function; recovery; salbutamol; salmeterol;
D O I
10.1046/j.1365-2125.2003.01887.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims Inhalers combining long acting beta(2)-adrenoceptor agonists (LABA) and corticosteroids (ICS) are indicated at Step 3 of current asthma guidelines. We evaluated the relative effects of LABA + ICS combination vs ICS alone on pulmonary function, bronchoprotection, acute salbutamol recovery following methacholine bronchial challenge, and surrogate inflammatory markers in patients with moderate persistent asthma. Methods Twenty-nine patients with mean FEV1 (+/- SEM) of 78 +/- 3% predicted completed a randomized, double-blind, double-dummy, cross-over study. Patients received either 4 weeks of budesonide 400 mug + formoterol 12 mug (BUD + FM) combination twice daily followed by 1 week of BUD 400 mug alone twice daily, or 4 weeks of fluticasone propionate 250 mug + salmeterol 50 mug (FP + SM) combination twice daily followed by 1 week of FP 250 mug alone twice daily. Measurements were made at baseline and following each randomized treatment. Results FEV1 increase from pretreatment baseline as mean (+/- SEM) % predicted was significantly higher (P < 0.05) for BUD + FM (8 +/- 1%) vs BUD (2 +/- 1%), and for FP + SM (8 +/- 1%) vs FP (2 +/- 1%). The fall in FEV1 following methacholine challenge as percentage change from prechallenge baseline FEV1 was not significantly different in all four groups; BUD + FM (22 +/- 1%), BUD (24 +/- 1%), FP + SM (23 +/- 1%) and FP (23 +/- 1%). Salbutamol recovery over 30 min following methacholine challenge as area under curve (AUC %.min) was significantly blunted (P < 0.05) with BUD + FM (486.7 +/- 35.5) vs BUD (281.1 +/- 52.8), and with FP + SM (553.1 +/- 34.1) vs FP (368.3 +/- 46.7). There were no significant differences between respective combination inhalers or between respective ICS alone. Decreases in exhaled nitric oxide (NO) and serum eosinophilic cationic protein (ECP) from baseline were not significantly different between treatments. Conlusions Combination inhalers improve pulmonary function without potentiating anti-inflammatory effects on exhaled NO and serum ECP as compared with ICS alone, but delay acute salbutamol recovery after bronchoconstriction.
引用
收藏
页码:494 / 500
页数:7
相关论文
共 44 条
[2]  
[Anonymous], 1987, AM REV RESPIR DIS, V136, P225
[3]   Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma [J].
Aubier, M ;
Pieters, WR ;
Schlösser, NJJ ;
Steinmetz, KO .
RESPIRATORY MEDICINE, 1999, 93 (12) :876-884
[4]   Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults [J].
Aziz, I ;
Wilson, AM ;
Lipworth, BJ .
CHEST, 2000, 118 (04) :1049-1058
[5]   In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol [J].
Aziz, I ;
Lipworth, BJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (05) :816-822
[6]   Comparative trough effects of formoterol and salmeterol on lymphocyte β2-adrenoceptor -: regulation and bronchodilatation [J].
Aziz, I ;
McFarlane, LC ;
Lipworth, BJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (06) :431-436
[7]   Subsensitivity to bronchoprotection against adenosine monophosphate challenge following regular once-daily formoterol [J].
Aziz, I ;
Tan, KS ;
Hall, IP ;
Devlin, MM ;
Lipworth, BJ .
EUROPEAN RESPIRATORY JOURNAL, 1998, 12 (03) :580-584
[8]   MEASUREMENT OF AIRWAY RESPONSIVENESS TO METHACHOLINE - RELATIVE IMPORTANCE OF THE PRECISION OF DRUG DELIVERY AND THE METHOD OF ASSESSING RESPONSE [J].
BEACH, JR ;
YOUNG, CL ;
AVERY, AJ ;
STENTON, SC ;
DENNIS, JH ;
WALTERS, EH ;
HENDRICK, DJ .
THORAX, 1993, 48 (03) :239-243
[9]   RAPID ONSET OF TOLERANCE TO THE BRONCHOPROTECTIVE EFFECT OF SALMETEROL [J].
BHAGAT, R ;
KALRA, S ;
SWYSTUN, VA ;
COCKCROFT, DW .
CHEST, 1995, 108 (05) :1235-1239
[10]   The effect of salmeterol on markers of airway inflammation following segmental allergen challenge [J].
Calhoun, WJ ;
Hinton, KL ;
Kratzenberg, JJ .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (04) :881-886